ES2093752T3 - Complejos de hierro que contienen conalbumina y sus derivados. - Google Patents

Complejos de hierro que contienen conalbumina y sus derivados.

Info

Publication number
ES2093752T3
ES2093752T3 ES92117269T ES92117269T ES2093752T3 ES 2093752 T3 ES2093752 T3 ES 2093752T3 ES 92117269 T ES92117269 T ES 92117269T ES 92117269 T ES92117269 T ES 92117269T ES 2093752 T3 ES2093752 T3 ES 2093752T3
Authority
ES
Spain
Prior art keywords
derivatives
iron complexes
complexes containing
containing albumin
presented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92117269T
Other languages
English (en)
Spanish (es)
Inventor
Gianni Ferrari
Pier Giuseppe Pagella
Oscar Baiardo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mediolanum Farmaceutici SpA
Original Assignee
Mediolanum Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediolanum Farmaceutici SpA filed Critical Mediolanum Farmaceutici SpA
Application granted granted Critical
Publication of ES2093752T3 publication Critical patent/ES2093752T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES92117269T 1991-10-16 1992-10-09 Complejos de hierro que contienen conalbumina y sus derivados. Expired - Lifetime ES2093752T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI912738A IT1251702B (it) 1991-10-16 1991-10-16 Complessi del ferro con la conalbumina e i suoi derivati

Publications (1)

Publication Number Publication Date
ES2093752T3 true ES2093752T3 (es) 1997-01-01

Family

ID=11360878

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92117269T Expired - Lifetime ES2093752T3 (es) 1991-10-16 1992-10-09 Complejos de hierro que contienen conalbumina y sus derivados.

Country Status (6)

Country Link
US (1) US5284832A (cg-RX-API-DMAC7.html)
EP (1) EP0537634B1 (cg-RX-API-DMAC7.html)
AT (1) ATE141612T1 (cg-RX-API-DMAC7.html)
DE (1) DE69212947T2 (cg-RX-API-DMAC7.html)
ES (1) ES2093752T3 (cg-RX-API-DMAC7.html)
IT (1) IT1251702B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5441643A (en) * 1993-11-29 1995-08-15 The United States Of America As Represented By The Secretary Of The Interior Process for recovering metals from solution utilizing metalloprotein affinity chromatography
IT1291289B1 (it) * 1997-04-30 1999-01-07 Derivati Organici Lab Complessi costituiti da fe(iii) un composto poliidrossilato e ovalbumina
US6693211B2 (en) 2002-05-15 2004-02-17 Geneva Pharmaceuticals, Inc. Chemical process
US7964568B2 (en) * 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
US20070077313A1 (en) * 2005-10-04 2007-04-05 U.S. Pharmaceutical Corporation Toleration iron supplement compositions
JP7190286B2 (ja) * 2018-08-30 2022-12-15 昭和電工株式会社 Ａｌ－Ｆｅ－Ｅｒ系アルミニウム合金
EP4046649A1 (en) 2021-02-22 2022-08-24 Bioseutica B.V. Ovotransferrins for use in the treatment of iron deficiency anaemia

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US505986A (en) * 1893-10-03 Pio marfori
US523688A (en) * 1894-07-31 Oswald schmiedeberg
US929452A (en) * 1906-05-14 1909-07-27 Ernst Laves Soluble-iron-albuminate preparation.
US1027967A (en) * 1910-06-30 1912-05-28 Walther Wolff And Company G M B H Dr Art of preparing iron-albuminous compounds containing phosphorus.
IT1048150B (it) * 1973-10-31 1980-11-20 O T I Officina Terapeutica Ita Metodo per l isolamento delle transferine da materiali biologici
IT1150213B (it) * 1982-03-02 1986-12-10 Italfarmaco Spa Derivati di ferro biodisponibile esenti da gastrolesivita',procentimento di preparazione e relative composizioni farmaceutiche
IT1207996B (it) * 1986-03-18 1989-06-01 Magis Farmaceutici Composti contenenti ferro biodisponibile, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT1223122B (it) * 1987-11-13 1990-09-12 Unibios Spa Derivati proteici del ferro altamente biodisponibile e tollerabili, loro preparazione e composizioni farmaceutiche che li contengono
JPH021500A (ja) * 1988-02-26 1990-01-05 Q P Corp コンアルブミン及びその金属複合体の製造方法
AU636104B2 (en) * 1989-01-09 1993-04-22 Meiji Milk Products Co., Ltd. Anti-hiv agent
EP0426924A1 (en) * 1989-11-09 1991-05-15 Cellena (Cell Engineering) A.G. Production of metal transporter compositions for facilitating the engraftment of histo-incompatible bone marrow and controlling the immune reactions in the recipient host
IT1237783B (it) * 1989-11-16 1993-06-17 Italfarmaco Spa Derivati di ferro-albumina biodisponibile, loro procedimento di preparazione e relative composizioni farmaceutiche.
IT1251725B (it) * 1991-11-04 1995-05-23 Italfarmaco Spa Composti di ferro biodisponibile con ovotransferrina acilata o suoi derivati di idrolisi acilati

Also Published As

Publication number Publication date
EP0537634B1 (en) 1996-08-21
DE69212947T2 (de) 1997-01-23
ITMI912738A0 (it) 1991-10-16
EP0537634A2 (en) 1993-04-21
ITMI912738A1 (it) 1993-04-16
DE69212947D1 (de) 1996-09-26
US5284832A (en) 1994-02-08
IT1251702B (it) 1995-05-19
ATE141612T1 (de) 1996-09-15
EP0537634A3 (cg-RX-API-DMAC7.html) 1994-05-04

Similar Documents

Publication Publication Date Title
ES2084944T3 (es) Amidas terapeuticas.
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2126766T3 (es) 7-azaindol-3-ilcarboxiamidas de tropilo como agente antitusivo.
SE8700498L (sv) Nya farmakologiskt aktiva foreningar
IT1178235B (it) Composizioni farmaceutiche contenenti sucralfat e procedimento per la loro stabilizzazione
DK393187D0 (da) Laegemiddel med antitumorvirkning
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
HUT51269A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
MX9207494A (es) 4(5)-amino-1,8-naftiridinas substituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ES2093752T3 (es) Complejos de hierro que contienen conalbumina y sus derivados.
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
IL58103A0 (en) Sila-substituted 1,4-dihydropyridine derivatives their production and pharmaceutical compositions containing them
ES2127263T3 (es) Nuevos trien-derivados cromenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2100396T3 (es) Derivados de 17-(3-furil)- y 17-(4-piridazinil)-5beta,14beta-androstano activos sobre el sistema cardiovascular, procesos para su preparacion y composiciones farmaceuticas que los contienen.
ES433860A1 (es) Procedimiento de preparacion de derivados del acido ciclo- pentano-carboxilico.
ATE111883T1 (de) Neue antiulcus-substanz.
ES2104917T3 (es) Bis-naftalimidas que contienen engarces amido y tioamido como agentes anticancerosos.
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
DE3060669D1 (en) Phenylalanyl-tryptophan derivatives, pharmaceutical compositions containing them, their preparation and use
IL106289A (en) Phospholipid derivatives their preparation and pharmaceutical compositions containing them
ES2162986T3 (es) Derivados de mercapto-alcanoil-dipeptidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2054029T3 (es) Formulacion de acetato de flecainida con liberacion controlada.
ES2032209T3 (es) Derivados de proteinas que contienen hierro en forma altamente biodisponible, su preparacion y composiciones farmaceuticas que los contienen.
ES2055700T3 (es) Mezclas bactericidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 537634

Country of ref document: ES